CompanyGraph
Guangyuyuan Chinese Herbal Medicine Co., Ltd.
600771 · SSE · China
guangyuyuan.comFinancials as of FY2025
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleLevered free cash flow is $30.67M, above the global median of $16.24M
- FinancialsAltman Z-Score 6.07: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.81BCNY1.01B · vs all stocks (USD)
Trailing P/E
96.36xRevenue (TTM)
1.44BCNY214.20M · vs all stocks (USD)
Profit Margin
4.60%Beta
0.2950xvs all stocks
52-Week Change
-34.71%vs all stocks
Market Capitalization
6.81BCNY1.01B · vs all stocks (USD)
Enterprise Value
6.35BCNY944.86M · vs all stocks (USD)
Trailing P/E
96.36xForward P/E
7.98xPrice to Sales (TTM)
4.58xPrice to Book (MRQ)
3.89xEnterprise to Revenue
4.41xEnterprise to EBITDA
38.75xGross Margin
67.89%Profit Margin
4.60%Operating Margin
15.44%Return on Assets (TTM)
3.30%Return on Equity (TTM)
4.00%Revenue (TTM)
1.44BCNY214.20M · vs all stocks (USD)
Revenue per Share (TTM)
2.97CNYUpdated Aug 20, 2026Quarterly Revenue Growth
17.00%Gross Profit (TTM)
969.93MCNY144.24M · vs all stocks (USD)
EBITDA (TTM)
178.31MCNY26.52M · vs all stocks (USD)
Net Income (TTM)
66.20MCNY9.84M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.00%Operating Cash Flow (TTM)
175.81MCNY26.14M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
206.24MCNY30.67M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
20.35MCNYFY2025 · Dec 31, 2025Revenue
1.37BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
443.70MCNYFY2025 · Dec 31, 2025Gross Profit
925.60MCNYFY2025 · Dec 31, 2025Operating Income
138.89MCNY20.65M · vs all stocks (USD)
Pre-tax Income
103.04MCNYFY2025 · Dec 31, 2025Income Tax Expense
39.35MCNYFY2025 · Dec 31, 2025Net Income
63.69MCNYFY2025 · Dec 31, 2025EBIT
105.56MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
178.31MCNYFY2025 · Dec 31, 2025Research & Development
38.47MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
542.65MCNYFY2025 · Dec 31, 2025Other Operating Expenses
32.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.16MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.52MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
484.95MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
484.95MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
63.69MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-646.07KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-3.57MCNYFY2025 · Dec 31, 2025Free Cash Flow
-9.81MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
296.73MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
63.69MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.15MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-82.05MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
11.65MCNYFY2025 · Dec 31, 2025Capital Expenditures
-6.24MCNYFY2025 · Dec 31, 2025Purchase of Investments
-600.00KCNYFY2025 · Dec 31, 2025Sale of Investments
468.65KCNYFY2025 · Dec 31, 2025Other Investing Activity
-10.18MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-16.55MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-8.14MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.19MCNYFY2025 · Dec 31, 2025Other Financing Charges
9.33MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
370.00CNYFY2025 · Dec 31, 2025Shares Outstanding
489.49MSharesUpdated Aug 20, 2026Float Shares
317.19MSharesUpdated Aug 20, 2026% Held by Insiders
21.12%vs all stocks
% Held by Institutions
1.77%vs all stocks
Total Cash (MRQ)
411.43MCNY61.18M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.8410CNYUpdated Aug 20, 2026Total Debt (MRQ)
31.13MCNY4.63M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0181xCurrent Ratio (MRQ)
2.20xBook Value per Share (MRQ)
3.47CNYUpdated Aug 20, 2026Total Assets
2.44BCNY362.37M · vs all stocks (USD)
Total Current Assets
1.58BCNYFY2025 · Dec 31, 2025Total Liabilities
783.77MCNYFY2025 · Dec 31, 2025Total Non-current Assets
853.19MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
47.31MCNYFY2025 · Dec 31, 2025Total Current Liabilities
736.46MCNYFY2025 · Dec 31, 2025Cash
285.29MCNYFY2025 · Dec 31, 2025Cash Equivalents
11.46MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
296.75MCNYFY2025 · Dec 31, 2025Accounts Receivable
269.60MCNYFY2025 · Dec 31, 2025Inventory
749.98MCNYFY2025 · Dec 31, 2025Accounts Payable
107.57MCNYFY2025 · Dec 31, 2025Short-term Debt
21.10MCNYFY2025 · Dec 31, 2025Other Current Liabilities
26.45MCNYFY2025 · Dec 31, 2025Long-term Debt
25.07MCNYFY2025 · Dec 31, 2025Common Stock (Book)
489.49MCNYFY2025 · Dec 31, 2025Retained Earnings
-471.18MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.65BCNY245.82M · vs all stocks (USD)
52-Week Low
12.45CNYUpdated Aug 20, 202652-Week High
21.66CNYUpdated Aug 20, 202652-Week Change
-34.71%vs all stocks
Beta
0.2950xvs all stocks
50-Day MA
14.16CNYUpdated Aug 20, 2026200-Day MA
16.70CNYUpdated Aug 20, 2026Avg 10-Day Volume
9.77MSharesUpdated Aug 20, 2026Avg 30-Day Volume
10.78MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.1400CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.68Profit Margin: 0.05
Financial Health
Altman Z-Score 6.07: safe zoneNotable
Altman Z-Score: 6.07
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Levered free cash flow is $30.67M, above the global median of $16.24MNotable
Levered free cash flow (USD): 30,670,661.829Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
BioAge Labs, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Edan Instruments Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hainan Haiyao Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Avalo Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pacira BioSciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Cisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Olema Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Ausun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Aidea Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
KPC Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Shanghai Mechanical and Electrical Industry Co., Ltd.
1 interpretationPrice Below Mean With Profitability And Book Value
ZJAMP Group Co., Ltd.
1 interpretationPrice Below Mean With Profitability And Book Value
China Marine Information Systems Company Limited
1 interpretationPrice Below Mean With Profitability And Book Value